Inpharma Weekly

, Volume 1647, Issue 1, pp 5–5 | Cite as

Dihydroergotamine mesilate for migraine: phase III trial initiated

Media release
  • 5 Downloads

Keywords

Placebo Clinical Trial Migraine Primary Endpoint Pain Relief 

Copyright information

© Adis International Ltd 2008

Personalised recommendations